DTL (denticleless E3 ubiquitin protein ligase), also known as CDT2/RAMP/DCAF2/L2DTL, has an oncogenic function in several cancer types, such as breast cancer, hepatocellular carcinoma (HCC), gastric cancer, and Ewing sarcoma [26–30]. This evidence concerns the gene DTL and hepatocellular carcinoma.